Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,846,360
+$1,242,295 QoQ
Shares Held
13,737
+40.7% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#281
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $489,021,807 across 24 Diagnostics & Research names. LH ranks #14 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
407,064 | $204,085,607 | |
| 2 | DHR |
Danaher Corp /De/
|
434,552 | $82,773,464 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
42,357 | $54,111,491 | |
| 4 | NTRA |
Natera, Inc.
|
147,253 | $39,971,826 | |
| 5 | WAT |
Waters Corp /De/
|
64,865 | $24,326,969 | |
| 6 | A |
Agilent Technologies, Inc.
|
136,377 | $18,114,956 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
30,147 | $15,870,586 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
16,625 | $8,804,433 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,846,360 | 13,737 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,604,065 | 9,760 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,481,454 | 9,891 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,168,919 | 21,490 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,528,786 | 28,680 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,992,524 | 34,341 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,697,125 | 33,565 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,839,678 | 35,080 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,094,358 | 34,860 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||